CompletedPHASE1, PHASE2NCT00004105

Combination Chemotherapy in Treating Patients With Advanced Cancer

Studying Acute mast cell leukemia

Last synced from ClinicalTrials.gov May 5, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: NYU Langone Health
Principal Investigator: Franco M. Muggia, MD
NYU Langone Health
Intervention: estramustine phosphate sodium(drug)
Eligibility: 18 years · All sexes
Timeline: 1998

Study locations (1)

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00004105 on ClinicalTrials.gov

Other trials for Acute mast cell leukemia

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE1, PHASE2NCT06213636
Fourth-gen CAR T Cells Targeting CD19/CD22 for Highly Resistant B-cell Lymphoma/Leukemia (PMBCL/CNS-BCL).
Essen Biotech

See all trials for Acute mast cell leukemia →

← Back to all trials